Detalhe da pesquisa
1.
Hepatitis B virus and hepatitis C virus affect mitochondrial function through different metabolic pathways, explaining virus-specific clinical features of chronic hepatitis.
J Infect Dis
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38655824
2.
Inhibition of cellular factor TM6SF2 suppresses secretion pathways of Hepatitis B, Hepatitis C and Hepatitis D viruses.
J Infect Dis
; 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38408366
3.
PEMT Mediates Hepatitis C Virus-Induced Steatosis, Explains Genotype-Specific Phenotypes and Supports Virus Replication.
Int J Mol Sci
; 24(10)2023 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37240132
4.
Hepatitis C Virus (HCV) Eradication With Interferon-Free Direct-Acting Antiviral-Based Therapy Results in KLRG1+ HCV-Specific Memory Natural Killer Cells.
J Infect Dis
; 223(7): 1183-1195, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32777077
5.
HBV vaccination and HBV infection induces HBV-specific natural killer cell memory.
Gut
; 70(2): 357-369, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32229546
6.
Expansion of dysfunctional CD56-CD16+ NK cells in chronic hepatitis B patients.
Liver Int
; 41(5): 969-981, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33411395
7.
Epidemiology of Coronavirus Disease in Gansu Province, China, 2020.
Emerg Infect Dis
; 26(6): 1257-1265, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32168465
8.
Correction: The paradox of HBV evolution as revealed from a 16th century mummy.
PLoS Pathog
; 14(2): e1006887, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29425240
9.
The paradox of HBV evolution as revealed from a 16th century mummy.
PLoS Pathog
; 14(1): e1006750, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29300782
10.
COVID-19: The Immune Responses and Clinical Therapy Candidates.
Int J Mol Sci
; 21(15)2020 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32756480
11.
KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B.
J Hepatol
; 71(2): 252-264, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30905683
12.
Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology.
Scand J Gastroenterol
; 53(8): 986-993, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29987961
13.
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes.
Hepatology
; 64(1): 34-46, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26822232
14.
FibroGENE: A gene-based model for staging liver fibrosis.
J Hepatol
; 64(2): 390-398, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26592354
15.
Calsyntenin-1 mediates hepatitis C virus replication.
J Gen Virol
; 97(8): 1877-1887, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27221318
16.
Instrumental support to facilitate hepatitis C treatment adherence: working around shortfalls in shared-care.
Psychol Health Med
; 20(2): 186-97, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-24998883
17.
Hepatitis C Virus Genotype 8 Infection-Successful Treatment With Sofosbuvir/Velpatasvir.
J Infect Dis
; 220(4): 720-722, 2019 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30958539
18.
Cross-genotypic examination of hepatitis C virus polymerase inhibitors reveals a novel mechanism of action for thumb binders.
Antimicrob Agents Chemother
; 58(12): 7215-24, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25246395
19.
Hepatitis C virus infection mediates cholesteryl ester synthesis to facilitate infectious particle production.
J Gen Virol
; 95(Pt 9): 1900-1910, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24859394
20.
Endocannabinoid CB1 antagonists inhibit hepatitis C virus production, providing a novel class of antiviral host-targeting agents.
J Gen Virol
; 95(Pt 11): 2468-2479, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25053565